The contribution of P-glycoprotein to clinical pharmacokinetic interactions between lenalidomide and temsirolimus

被引：0

作者：

Yang, Xiaoxia ^{[1
]}

Craig, Hofmeister C. ^{[1
]}

Rozewski, Darlene M. ^{[1
]}

Lee, Seungsoo ^{[1
]}

Chen, Ping ^{[1
]}

Johnson, Amy J. ^{[1
]}

Liu, Zhongfa ^{[1
]}

Hade, Erinn M. ^{[1
]}

Ji, Jia ^{[1
]}

Schaaf, Larry J. ^{[1
]}

Benson, Don M. ^{[1
]}

Kraut, Eric H. ^{[1
]}

Hicks, William J. ^{[1
]}

Chan, Kenneth K. ^{[1
]}

Chen, Ching-Shih ^{[1
]}

Farag, Sherif S. ^{[2
]}

Grever, Michael R. ^{[1
]}

Byrd, John C. ^{[1
]}

Phelps, Mitch A. ^{[1
]}

机构：

[1] Ohio State Univ, Columbus, OH 43210 USA

[2] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA

来源：

CANCER RESEARCH | 2011年 / 71卷

关键词：

D O I：

10.1158/1538-7445.AM2011-5473

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5473

引用

页数：1

共 50 条

[31] No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
Nianhang. Chen
Daniel Weiss
Josephine Reyes
Liangang Liu
Claudia Kasserra
Xiaomin Wang
Simon Zhou
Gondi Kumar
Lilia Weiss
Maria Palmisano
Cancer Chemotherapy and Pharmacology, 2014, 73 : 1031 - 1039
[32] Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings
O'Brien, Fionn E.
Dinan, Timothy G.
Griffin, Brendan T.
Cryan, John F.
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (02) : 289 - 312
[33] Clinical Pharmacokinetic and Metabolism of PET Radiotracers for Imaging P-glycoprotein in Chemoresistant Tumor of Colorectal Cancer
Cantore, Mariangela
Capparelli, Elena
Berardi, Francesco
Perrone, Roberto
Colabufo, Nicola Antonio
CURRENT DRUG METABOLISM, 2011, 12 (10) : 985 - 988
[34] Role of P-glycoprotein in pharmacokinetics - Clinical implications
Lin, JH
Yamazaki, M
CLINICAL PHARMACOKINETICS, 2003, 42 (01) : 59 - 98
[35] Mapping transporter interactions of reference P-glycoprotein inhibitors
Jani, Marton
DRUG METABOLISM REVIEWS, 2011, 43 : 206 - 206
[36] Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
Nianhang Chen
Daniel Weiss
Josephine Reyes
Liangang Liu
Claudia Kasserra
Xiaomin Wang
Simon Zhou
Gondi Kumar
Lilia Weiss
Maria Palmisano
Cancer Chemotherapy and Pharmacology, 2014, 74 : 659 - 660
[37] Clinical pharmacology of P-glycoprotein and related transporters
Woodcock, BG
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (01) : 1 - 2
[38] P-glycoprotein interactions of nefazodone and trazodone in cell culture
Störmer, E
van Moltke, LL
Perloff, MD
Greenblatt, DJ
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (07): : 708 - 714
[39] P-glycoprotein function in human alloimmune interactions.
Frank, MH
Sayegh, MH
Briscoe, DM
TRANSPLANTATION, 2000, 69 (08) : S131 - S131
[40] Clinical relevance of P-glycoprotein in drug therapy
Lin, JH
Yamazaki, M
DRUG METABOLISM REVIEWS, 2003, 35 (04) : 417 - 454

← 1 2 3 4 5 →